Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions

Details for Australian Patent Application No. 2005302032 (hide)

Owner The Procter & Gamble Company

Inventors Jessen, George William; Khanolkar, Jayant Ekanth; Rennie, Paul John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005302032

PCT Pub. Number WO2006/050489

Priority 10/979,498 02.11.04 US

Filing date 1 November 2005

Wipo publication date 11 May 2006

Acceptance publication date 17 November 2011

International Classifications

A61K 31/765 (2006.01)

A61K 33/30 (2006.01) Medicinal preparations containing inorganic active ingredients - Zinc

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/050489 Priority application(s): WO2006/050489

17 November 2011 Application Accepted

  Published as AU-B-2005302032

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005302040-A device and method for the therapy of obesity

2005302031-Apparatus and method for retroactively installing sensors on marine elements